We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$805M
AUM Growth
+$2.82M
Cap. Flow
-$5.52M
Cap. Flow %
-0.69%
Top 10 Hldgs %
21.48%
Holding
266
New
7
Increased
69
Reduced
92
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.49M
2
JAH
JARDEN CORPORATION
JAH
+$861K
3
AGN
Allergan plc
AGN
+$842K
4
LH icon
Labcorp
LH
+$776K
5
ECL icon
Ecolab
ECL
+$712K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.98M
2
AGN
Allergan Inc
AGN
+$1.74M
3
GILD icon
Gilead Sciences
GILD
+$1.33M
4
TFM
THE FRESH MARKET, INC COM STK
TFM
+$1.26M
5
CELG
Celgene Corp
CELG
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 18.07%
2 Industrials 14.98%
3 Miscellaneous 14.57%
4 Technology 12.91%
5 Consumer Staples 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
226
Unilever
UL
$134B
$294K 0.04%
6,262
– –
HRB icon
227
H&R Block
HRB
$5.65B
$289K 0.04%
9,000
– –
STE icon
228
Steris
STE
$20.5B
$281K 0.03%
4,000
– –
DTV
229
DELISTED
DIRECTV COM STK (DE)
DTV
$280K 0.03%
3,289
-50
-1% -$4.32K
COHR
230
DELISTED
Coherent Inc
COHR
$279K 0.03%
4,300
– –
VT icon
231
Vanguard Total World Stock ETF
VT
$80.6B
$277K 0.03%
4,500
– –
TTE icon
232
TotalEnergies
TTE
$206B
$276K 0.03%
5,548
-3,000
-35% -$154K
FISV
233
Fiserv Inc
FISV
$26.6B
$269K 0.03%
6,770
– –
CTSH icon
234
Cognizant
CTSH
$28.5B
$264K 0.03%
4,230
+290
+7% +$17.1K
NMM icon
235
Navios Maritime Partners
NMM
$2.69B
$262K 0.03%
1,570
– –
EWG icon
236
iShares MSCI Germany ETF
EWG
$1.68B
$256K 0.03%
8,563
– –
DUK icon
237
Duke Energy
DUK
$91.8B
$252K 0.03%
3,283
-33
-1% -$2.68K
IVV icon
238
iShares Core S&P 500 ETF
IVV
$837B
$245K 0.03%
1,180
– –
CMCSA icon
239
Comcast
CMCSA
$86.7B
$243K 0.03%
8,610
– –
SAIC icon
240
Saic
SAIC
$5.6B
$235K 0.03%
4,585
– –
CYBX
241
DELISTED
CYBERONICS INC
CYBX
$234K 0.03%
3,600
– –
ICEL
242
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
$227K 0.03%
13,800
-43,625
-76% -$280K
AVY icon
243
Avery Dennison
AVY
$13B
$225K 0.03%
4,250
– –
TWC
244
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$225K 0.03%
1,500
– –
SYY icon
245
Sysco
SYY
$38.1B
$224K 0.03%
5,950
– –
EQT icon
246
EQT Corp
EQT
$33.2B
$220K 0.03%
4,868
– –
WPC icon
247
W.P. Carey
WPC
$15.6B
$214K 0.03%
3,216
+25
+0.8% +$1.72K
TXN icon
248
Texas Instruments
TXN
$241B
$212K 0.03%
+3,704
New +$208K
CMI icon
249
Cummins
CMI
$74.1B
$208K 0.03%
1,500
– –
ELV icon
250
Elevance Health
ELV
$90.6B
$208K 0.03%
+1,349
New +$192K
7 8 9
10
11

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q1 2015 Portfolio in Review

As of Q1 2015, Boston Family Office held 266 positions worth $805M, up 0.35% from $803M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2015 filing shows 7 new, 69 increased, 92 reduced and 7 closed positions. Its largest new stake was Medtronic: 19,713 shares worth $1.54M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q1 2015 buy was Medtronic: 19,713 shares worth $1.54M.
  • Boston Family Office added most to Allergan plc in Q1 2015, an estimated $842K increase.
  • Boston Family Office's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $1.33M.
  • Boston Family Office fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.98M.
  • Boston Family Office's ten largest holdings make up 21% of its $805M portfolio in Q1 2015.
  • Boston Family Office opened 7 new positions and closed 7 in Q1 2015.
  • Boston Family Office's portfolio value rose 0.35% quarter-over-quarter to $805M.

Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.